Table 6.

Frequency of grades 3 and 4 toxicities, at least possibly related to study treatment, occurring during the first four cycles of study treatment, among patients in ovarian cancer cohort (n = 24)

ToxicityGrade 3, n (%)Grade 4, n (%)
Febrile neutropenia1 (4)1 (4)
Neutropenia4 (17)17 (71)
Lymphopenia9 (38)0
WBC count13 (54)4 (17)
Anemia3 (13)0
Thrombocytopenia00
Rash/desquamation1 (4)0
Dehydration1 (4)0
Infection, without neutropenia1 (4)0
International normalized ratio1 (4)0